张君,任鹏飞,田黎,等.海洋芽孢杆菌B-9987中抗MDR菌活性成分研究[J].中国海洋药物,2016,35(5):45-49.
海洋芽孢杆菌B-9987中抗MDR菌活性成分研究
Identification of anti-MDRB compounds from the marine-derived Bacillus sp. B-9987
投稿时间:2016-01-23  修订日期:2016-02-26
DOI:
中文关键词:  海洋芽孢杆菌B-9987  多重耐药菌  Macrolactin  Bacillaene
English Keywords:Marine Bacillus sp. B-9987  multi-drug resistant bacteria (MDRB)  Macrolactin  Bacillaene
Fund Project:
作者单位E-mail
张君 教育部海洋药物重点实验室 zhangjunlichao@sina.com 
任鹏飞 教育部海洋药物重点实验室  
田黎 国家海洋局第一海洋研究所、青岛科技大学化工学院  
李花月 教育部海洋药物重点实验室  
李文利* 教育部海洋药物重点实验室 liwenli@ouc.edu.cn 
摘要点击次数: 4212
全文下载次数: 1127
中文摘要:
      挖掘具有优良多重耐药菌(MDR)抗菌活性的次级代谢产物,为海洋新药研发提供分子多样性。方法 对海洋芽孢杆菌B-9987进行大发酵,将发酵产物进行提取分离,每一步分离过程进行MDR活性追踪。结果 B-9987粗提物对4株MDR菌(金黄色葡萄球菌CCARM 3090、沙门氏菌CCARM 8250、大肠杆菌CCARM 1009、粪肠球菌CCARM 5203)具有良好的抗菌活性。通过HPLC分离纯化及MS、NMR等波谱分析获得了化合物1(Macrolactin F)和化合物2(Bacillaene A)。化合物1对MDR菌没有抗菌活性。由于化合物2对光、温度、氧气十分不稳定,无法直接测试活性。对含有化合物2的组分进行活性测试,确定了B-9987的MDR菌抗菌活性来自于Bacillaene类化合物。结论 鉴定了B-9987中的抗MDR菌活性成分。
English Summary:
      Objective:Discovery of antibacterial secondary metabolites against multi-drug resistant bacteria (MDRB) from marine-derived Bacillus sp. B-9987. Method The culture broth of B-9987 was extracted with EtOAc, and the EtOAc extract was further separated by open column chromatography. The pure compounds were finally obtained by HPLC purification, and their structures were determined by combination of MS and NMR data analysis. The antibacterial activity test against MDRB was carried out in each step of the separation process.
查看全文  查看/发表评论  下载PDF阅读器
关闭